Skip to main content

and
  1. Article

    Open Access

    Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

    Safety data is required to be collected in all clinical trials and can be separated into two types of data, adverse events and serious adverse events. Often, these types of safety data are collected as two dis...

    Elizabeth C. James, David Dunn, Adrian D. Cook, Andrew R. Clamp, Matthew R. Sydes in Trials (2020)

  2. Article

    Open Access

    Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms

    Monitoring and managing data returns in multi-centre randomised controlled trials is an important aspect of trial management. Maintaining consistently high data return rates has various benefits for trials, in...

    William J. Cragg, Fay Cafferty, Carlos Diaz-Montana, Elizabeth C. James in Trials (2019)